Health
Cure To Blindness: $850K Price
Published
9 years agoon
(via Zerohedge)
How much is a patient’s eyesight worth?
That’s a corollary question that a transformative medical treatment released by Spark Therapeutics seeks to answer. The treatment, known as Luxturna, has the potential to cure a rare genetically inherited form of blindness, according to Bloomberg.
Luxturna
The price tag? $850,000 – or $425,000 per eye.
A transformative genetic treatment for a rare, inherited form of blindness will come with a price tag of of $425,000 per eye, or $850,000 for both, said Spark Therapeutics Inc., the tiny biotechnology company that is bringing the therapy to market.
Since Spark’s Luxturna was approved by the U.S. Food and Drug Administration last month, speculation over the price has grown as it became clear the therapy would be one of the first in a wave of medicines that yield remarkable results after a single treatment – and would carry a commensurate cost.
Of course, few patients will pay the whole amount out-of-pocket. Even for the uninsured, Spark will offer discounts based on whether or not the drug works initially and remains effective for the estimated 1,000 to 2,000 patients in the US with the inherited retinal disease caused by the gene mutation that the medication treats.
Though the price tag also reflects what Spark CEO Jeff Marrazzo describes as the drug’s “life-altering” properties.
“We believe that this price reflects not only the breakthrough, life-altering value of one-time Luxturna, but it will enable us to continue to invest and build on the revolutionary science that supports not only Luxturna but the rest of our pipeline,” Chief Executive Officer Jeff Marrazzo said in a phone interview.
The company’s “novel” pricing scheme was devised to help placate insurers who don’t want to get stuck paying for the entire course of treatment if a patient changes plans while still enjoying the benefits of the treatment, which only needs to be administered one time.
A one-time treatment presented a challenge, since the cost would be paid for by one insurer or government, only to have others reap the benefits when the patient changes coverage.
To help mitigate that dynamic, Spark is rolling out several programs to spread out the cost over the years or give rebates to payers if the benefits wane with time.
For example, the company said it’s discussing a program with the U.S. Centers for Medicare & Medicaid Services that would spread payments for Luxturna over several years, even though the therapy would be given only once. It didn’t say how many installments would be made, or how long it would take to pay the full cost of the drug.
Insurers are also wary of getting stuck with the entire bill if the treatment proves ineffective, or if its benefits only persist for a brief period.
In an agreement with the Boston-area insurer Harvard Pilgrim Health Care, Spark will get the full price of treatment up front. If patients don’t get an immediate benefit – measured at 30 days, or a long term one – measured at 30 months, Spark will have to give some of the money back in a rebate.
Spark has also proposed selling the gene therapy directly to insurance companies or specialty pharmacies. That would sidestep the current process that requires hospitals or health care providers to buy expensive therapies upfront. Spark is working with Express Scripts Holding Co. on such an arrangement, and said it’s talking with other drug plans.
However, some insurers said they expected the drug to cost even more, considering the narrow customer base.
Express Scripts has been a frequent critic of costly drugs, yet said that the Spark treatment is an exception.
“Many people were anticipating this would be more than a million dollars” said Steve Miller, the St. Louis-based company’s chief medical officer. “In the end, this is a revolutionary product, and I think in most plans this will be covered.”
Spark’s biggest challenge may be finding patients to treat.
Of the few thousand people with the disease, only a few have actually been tested and confirmed to have it, since there was no cure, and thus little use in diagnosis. Many with more advanced forms of the disease won’t qualify for treatment, according to the company.
President Donald Trump has shaken pharmaceutical stocks, like he did back in October, when he criticized pharmaceutical companies for charging too much for their drugs, and nebulously threatened to do something about drug prices (though as of yet no direct action has been forthcoming).
However, Spark may need to raise the price if its medication if it doesn’t find enough people to treat. Only a few thousand people in the US possess the genetic mutation that the drug treats. And many of them won’t qualify for treatment.
Spark’s biggest challenge may be finding patients to treat.
Of the few thousand people with the disease, only a few have actually been tested and confirmed to have it, since there was no cure, and thus little use in diagnosis. Many with more advanced forms of the disease won’t qualify for treatment, according to the company.
So, what’s a specialty drug maker to do?
Health
Rob Sand Seeks Publicity While Zach Lahn Helps Iowa
Published
17 hours agoon
November 21, 2026
Governor-elect Rob Sand (@RobSandIA) waited four days to say anything about the Army’s plan to set off a lead bomb in southeast Iowa. When he finally did, he had nothing to offer but a press-release shrug. Since then? Crickets.
Here’s what happened. On Nov. 13, the EPA quietly issued an emergency permit letting the Army detonate degraded lead azide in place at the Iowa Army Ammunition Plant in Middletown, a town of about 300 people near Burlington. On Nov. 15, the Army posted its public advisory: two controlled detonations at about noon on Friday, Nov. 20. The plan covered 68 barrels, roughly 9,700 pounds of an explosive that has recrystallized and become so sensitive to friction and shock that the Army says it can’t safely be moved.
The Army’s own advisory included a plume map warning of toxic lead dust settling to the north, with children under six “especially vulnerable.” Residents near Middletown City Park were told to clear out from 8 a.m. to 2 p.m. ISU Extension told cattle producers to pull livestock off pasture and ponds and to watch for signs of lead poisoning, starting with “sudden death.” Gov. Kim Reynolds’ office says it learned of the plan Monday, Nov. 16.
Iowa had the whole weekend and most of the week to hear from the man about to take over the Statehouse. It got nothing.
Thursday morning, 11:35 a.m.
Sand finally posted at 11:35 a.m. Central on Thursday, Nov. 19. That was about four days after the Army’s advisory, six days after the EPA permit, and barely 24 hours before the scheduled blast. Here it is in full:
The safety of Iowans now and in the future should be government’s top concern.
An unacceptable lack of communication and clarity has made Iowans understandably concerned and angry about this situation. The public deserves to know, if this is the safest option, why other options…
— Rob Sand (@RobSandIA) November 19, 2026
Read it twice. Safety should be the “top concern.” Iowans are “understandably concerned.” The public “deserves to know.” Swap “lead azide” for a bridge closure or a boil order and every word still works. No mention of Middletown. No mention of the farmers, the cattle, the water, or the kids in the plume path. No demand of the Army, the EPA, or anyone in Washington. And not one idea of his own.
The last line is the tell: if it isn’t as safe as possible, it shouldn’t happen. That’s a hedge, not a position. It lets him say he called for a pause if the blast goes badly and say he never opposed the Army if it goes fine.
Where was Rob? Deer Valley, Utah.
Here’s the part that should make every Iowan in the plume path furious. While southeast Iowa was pulling kids out of school and moving cattle off pasture, Sand was at a ski resort in Utah. On Nov. 19, the same day as his three-paragraph statement and the day before the blast was supposed to go off, he sat for an onstage interview at the POLITICO Pub at the National Governors Association’s New Governors Leadership Forum in Deer Valley, Utah. What made news? Not Middletown. POLITICO’s headline: “Rob Sand shuts down any talk of 2028.” A second POLITICO video promises Sand talking about his “model past.”
MAHA activist Kelly Ryerson (@GlyphosateGirl) noticed. At 11:20 p.m. Friday, she asked the question a lot of Iowans were already asking:
Why is @RobSandIA mute on the lead bomb issue, but @ZachLahn is all over it? Guess who should have won the election?
— Kelly Ryerson (@GlyphosateGirl) November 21, 2026
Forty minutes later she followed up, saying Sand had “been busy hanging at a Politico event in Deer Valley instead. As people in the state are very alarmed and evacuating.” POLITICO’s own coverage backs her up on where he was.
And since that Thursday statement? Sand’s X feed has a tribute to the late Sen. Wally Horn, a salute emoji, and on Saturday morning a string of jokey replies, one asking “Red hair, Niles?” and another calling something “the nicest thing anyone has ever said about me.” On the barrels in Middletown, not one new word.
Lahn was there first, with a plan
Zach Lahn doesn’t hold office. He lost this race. He was still out ahead of the governor-elect anyway.
At 8:47 p.m. Central on Wednesday, Nov. 18, roughly 15 hours before Sand said a word, Lahn went after the official line that lead dust can just be hosed off and stays “below levels of concern”:
Hosing off a chemical element sends it into the soil & water.
Lead is a neurotoxin that never biodegrades with zero safe exposure level.
But it’s "below levels of concern”. Exactly what we hear from the EPA on chemicals they regulate.
Our trust has been lost. pic.twitter.com/9r4ir9Qvf0
— Zach Lahn (@ZachLahn) November 19, 2026
At 9:38 a.m. Thursday, still two hours before Sand, he cut straight to it:
“When farmers have to keep cattle inside, off the water and grass, it’s clearly gone too far. We can catch a 250-ton rocket with chopsticks, but can’t dispose of an explosive without 100-mile neurotoxin plume? Pause, bring in the brightest minds, find another way.”
Then at 5:07 p.m. Thursday he did what Sand never did and laid out an actual plan. Lahn said he’d talked with people who know the situation, including officials in Washington, and he didn’t pretend there was a magic answer: “an unplanned detonation would clearly be the worst option.” He pointed out that the stockpile has reportedly been known about since 2004 with nothing done. Then he got specific:
Plan as if we’re going to detonate anyway. Keep every precaution in place.
Send in a robot instead of a person. Lahn proposed using an Optimus robot from @elonmusk to open each barrel and apply a chemical neutralizer like ceric ammonium nitrate, a documented way to break lead azide down into nitrogen gas, with nobody in harm’s way.
Accept that every outcome beats the status quo. Best case, it’s all neutralized and there’s no blast. Middle case, the blast is smaller. Worst case, a barrel goes off with every precaution already in place.
Make the Army pause. “The Army should pause tomorrow’s detonation long enough to think up crazy ideas that just may work.”
His bottom line: “Just going ahead as planned without trying to find a way to protect people, land, water, and soil is not an acceptable way to think about this.”
Before we blow up 68 barrels in Middletown and release a 100-mile lead plume, let's try something out of the box.
I've spoken with people who know this situation very well, including government officials in Washington, D.C.
Their take is that we have two options:
A) A planned…
— Zach Lahn (@ZachLahn) November 19, 2026
Call the robot idea a moonshot. Lahn did himself. It’s still a real idea. Sand’s contribution was a vibe. And for the record, the Army’s own environmental assessment rejected chemical neutralization because it would mean workers handling the drums for days or weeks. Taking the humans out of that equation is exactly the problem Lahn’s idea is aimed at.
Still working the phones
Lahn didn’t post once and move on. Nine minutes before midnight on Friday, he answered Ryerson directly:
One of the main reasons I ran is because I truly care about the health of our state. An election outcome doesn’t change that.
Have been on the phone w/officials in the WH tonight trying to help find other options.
Another environmental health issue is the last thing Iowa needs
— Zach Lahn (@ZachLahn) November 21, 2026
“One of the main reasons I ran is because I truly care about the health of our state. An election outcome doesn’t change that,” he wrote, adding that he’d “been on the phone w/officials in the WH tonight trying to help find other options.”
At 9:34 a.m. Saturday he posted an update. By Lahn’s account, HHS Secretary Robert F. Kennedy Jr. (@seckennedy) called him Friday night about his “deep concern” over the detonation, then connected him with Vice President JD Vance’s team and the White House, both of whom called late that night. Lahn says he can “say with certainty that they are looking at every available alternative.” He also says a former senior Defense Department official with decades in weapons threat reduction sent him an analysis, now shared with those offices, recommending an independent review by one of the National Laboratories to determine how urgent the threat really is. “If time allows,” Lahn wrote, “there are indeed other options available to mitigate the risk.”
Update: I received a call last night from @seckennedy regarding his deep concern about the Army's planned lead azide detonation in Middletown, Iowa.
He connected me with Vice President Vance’s team and the White House, both called late last night.
I can say with certainty that…
— Zach Lahn (@ZachLahn) November 21, 2026
That’s the difference. One guy lost the election and is calling the White House at midnight to find another way. The other guy won it, put out one statement, and went back to talking about 2028 and his hair.
Where it stands
Thursday evening, Acting Army Secretary Adam Telle pushed the blast to Monday, Nov. 23, calling it the “latest possible moment” before colder weather destabilizes the material further. Late Thursday night, the 8th Circuit Court of Appeals issued a temporary administrative stay of the EPA permit at the request of the Iowa Environmental Council and Sierra Club Iowa. As of Saturday, that stay is still in place.
But don’t relax yet. On Friday, Justice Department lawyers representing the EPA told the court they’ll fight the stay, with a full response due by Sunday. They also pointed to an EPA rule that lets the Army treat waste without a permit in a qualifying emergency. Earthjustice, which represents the environmental groups, called that “an extraordinary and extreme backstop” and urged the Army not to use it. The Army hasn’t said whether it will. Friday evening, Gov. Reynolds activated the State Emergency Operations Center. And on Saturday, the City of Fort Madison said it had been told the Army will “most likely” detonate on Monday, Nov. 23, or Tuesday, Nov. 24. So the Monday date may still be live, court stay or not.
For now, those barrels are still sitting in Middletown.
Southeast Iowa deserved a governor-elect who showed up early with answers. On this one, the guy who lost the race showed up first, and he’s still working the problem. Rob Sand showed up with talking points, then spent the day at a Utah ski resort talking about himself.
Health
President Trump Calls for Covid-19 Vaccine Transparency, Sec. RFK Jr. Praises Move
Published
1 year agoon
September 1, 2025
On September 1, 2025, President Donald Trump took to Truth Social to express concerns about the effectiveness of COVID-19 vaccines developed under his administration’s Operation Warp Speed. In his post, Trump highlighted “great numbers and results” from some pharmaceutical companies but demanded that they publicly release data to prove the vaccines’ success rates. He voiced frustration over the ongoing debate tearing apart the Centers for Disease Control and Prevention (CDC), urging transparency to resolve what he called a “MESS.” This statement reflects Trump’s evolving stance on the vaccines, which he once hailed as a major achievement, now aligning with growing skepticism within certain political circles.
The COVID-19 vaccines, rolled out in late 2020, have been credited by public health experts with saving millions of lives globally by reducing severe illness, hospitalizations, and deaths during the pandemic. However, they have also faced criticism for side effects in rare cases, waning efficacy against new variants, and questions about long-term data transparency from manufacturers. Trump’s demand for proof comes amid broader discussions on vaccine mandates and public trust, with some studies showing high effectiveness in initial trials but real-world challenges like breakthrough infections. This has fueled a polarized debate, where supporters emphasize the vaccines’ role in ending lockdowns, while detractors call for more accountability from drug companies.
Health and Human Services Secretary Robert F. Kennedy Jr., known for his vaccine-skeptical views, has been a key figure in recent policy shifts, drawing both praise for advocating scrutiny and criticism from former CDC officials who argue it endangers public health. Trump’s post appears to support Kennedy’s efforts to review vaccine data, potentially leading to changes in federal guidelines. While this push for evidence could enhance transparency, experts warn it might erode confidence in proven public health tools. As the administration navigates this issue, the focus remains on balancing accountability with scientific consensus to inform future health strategies.
Health
mRNA COVID-19 Injections Not Vaccines – Ninth Circuit Rules
Published
2 years agoon
June 9, 2024
In a recent decision that has stirred up discussions across the nation, the Ninth Circuit Court of Appeals ruled that the COVID-19 mRNA injections do not qualify as vaccines under traditional medical definitions. This decision was made in a lawsuit brought by the Health Freedom Defense Fund and other plaintiffs against the Los Angeles Unified School District (LAUSD). The court’s decision could potentially expose pharmaceutical companies to future liability lawsuits, as it challenges the legal protections typically afforded to vaccine manufacturers.
The lawsuit against LAUSD was based on the claim that the district’s vaccine mandate infringed upon the plaintiffs’ fundamental right to refuse medical treatment. The court, in a majority opinion authored by Circuit Judge R. Nelson and supported by Judge Collins, asserted that the mRNA shots, marketed as vaccines, do not effectively prevent the transmission of COVID-19 but merely reduce symptoms in those who contract the virus. This distinction, the court argued, means that the injections should not be considered vaccines under traditional medical definitions.
The implications of this ruling are significant. If mRNA injections are not considered vaccines, then they may not be subject to the same legal protections as traditional vaccines. This could potentially open the door to liability lawsuits against pharmaceutical companies that have produced and distributed the injections.
The court’s decision has sparked a range of reactions on social media. Some users have expressed relief and support for the ruling, viewing it as a step towards greater transparency and accountability in the handling of the pandemic. Others have criticized the decision, arguing that it undermines public health efforts and could discourage the use of potentially life-saving treatments.
The ruling has also reignited debates about the handling of the pandemic and the promotion of alternative treatments. Some have questioned the effectiveness of the mRNA injections, while others have pointed to the rapid development and deployment of these treatments as a remarkable achievement in the face of a global crisis.
As the legal implications of this ruling continue to unfold, it is likely that the debate surrounding the COVID-19 pandemic and the role of vaccines in public health will continue to evolve. The Ninth Circuit’s decision serves as a reminder of the complex legal and ethical issues at the heart of public health policy.
Rob Sand Seeks Publicity While Zach Lahn Helps Iowa
Will Notable Frazier: Watch The Water | Watch The Timeline
Rob Sand Must Be Audited Along with LGI
2028: America First Dark Horse Must Rise
Democrats Gave Ground on Their Wackiest Issues to “Win”
President Trump Must Audit the 2026 Midterms & Force Redo
President Trump’s Rally Blitz Will Maintain Control in D.C.
Rob Sand Seeks Publicity While Zach Lahn Helps Iowa
2028: America First Dark Horse Must Rise
